Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Transdermal rate-controlled delivery of Huperzine A for treatment of alzheimer's disease

Transdermal rate-controlled delivery of Huperzine A for treatment of alzheimer's disease

US Patent 6352715 · Granted Mar 5, 2002

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Matrix metalloproteinase (MMP) inhibitors and methods of use thereof2025
Matrix metalloproteinase (MMP) inhibitors and methods of use thereof2025
Matrix metalloproteinase (MMP) inhibitors and methods of use thereof2023
Case2023
Inflatable costume2023
Back cover of massage gun2023
Programmable and printable biofilms as engineered living materials2022
Matrix metalloproteinase (MMP) inhibitors and methods of use thereof2020
Medicament for prevention and treatment of bone fracture and osteoporosis2008
Seamless BB paintball2006
ST 188L as the prevention and treatment for cancers and infections2003
ST 188L as the prevention and treatment for cancers and infections2003